Compare CHDN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHDN | RGEN |
|---|---|---|
| Founded | 1928 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.6B |
| IPO Year | 1995 | 1995 |
| Metric | CHDN | RGEN |
|---|---|---|
| Price | $82.85 | $145.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $138.44 | ★ $167.67 |
| AVG Volume (30 Days) | 978.4K | ★ 1.2M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.43% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 5.49 | 0.24 |
| Revenue | ★ $1,809,800,000.00 | $141,236,000.00 |
| Revenue This Year | $5.75 | $14.30 |
| Revenue Next Year | $3.52 | $14.52 |
| P/E Ratio | ★ $15.36 | $587.54 |
| Revenue Growth | 13.31 | ★ 35.10 |
| 52 Week Low | $79.40 | $100.99 |
| 52 Week High | $118.35 | $175.77 |
| Indicator | CHDN | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 55.37 |
| Support Level | N/A | $139.40 |
| Resistance Level | $90.25 | $147.14 |
| Average True Range (ATR) | 2.84 | 7.40 |
| MACD | -0.12 | -0.40 |
| Stochastic Oscillator | 23.49 | 61.64 |
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.